The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Expected For The Leukapheresis Market At The End Of The 2026–2030 Forecast Period?
The leukapheresis market size has shown substantial expansion in recent years. This market is anticipated to expand from $72.02 billion in 2025 to $77.7 billion in 2026, registering a compound annual growth rate (CAGR) of 7.9%. The historical progression of this market can be ascribed to an increase in hematologic disorders, the broadening of cancer research initiatives, a greater utilization of apheresis in blood centers, enhancements in centrifugation technologies, and a rise in clinical research funding.
The leukapheresis market is poised for significant expansion over the coming years. This market is projected to reach $104.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.6%. This anticipated growth during the forecast period stems from factors such as the expansion of CAR-T and cell-based therapies, heightened investment in immunology research, a growing need for personalized medicine, the broadening scope of biopharmaceutical manufacturing, and advancements in apheresis automation technology. Key trends anticipated for this period encompass the escalating application of leukapheresis in cell and gene therapies, a surging requirement for immune cell collection in oncology, the increasing embrace of automated apheresis systems, the broader integration of leukapheresis into clinical research, and a heightened emphasis on disposable apheresis kits designed for patient safety.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24277&type=smp
Which Market Drivers Are Supporting The Expansion Of The Leukapheresis Market?
The increasing incidence of autoimmune diseases is projected to propel the growth of the leukapheresis market. Autoimmune diseases are conditions where the body’s immune system erroneously targets its own healthy tissues. A decline in early-life microbial exposure and contemporary environmental elements are unsettling immune balance, resulting in a higher number of autoimmune disorders. Leukapheresis aids in treating autoimmune diseases by selectively removing detrimental white blood cells that contribute to the immune system attacking the body’s own tissues. For example, according to GetValue.co, a US-based online digital platform, in September 2025, autoimmune diseases are estimated to impact 3–10% of the global population, which translates to approximately 600–800 million people worldwide. Therefore, the rising prevalence of autoimmune diseases is a key driver for the leukapheresis market’s expansion.
What Segment Types Make Up The Leukapheresis Market?
The leukapheresis market covered in this report is segmented –
1) By Apheresis Type: Granulocyte Apheresis, Lymphocyte Apheresis, Monocyte Apheresis
2) By Product: Leukapheresis Devices, Centrifugal Devices, Membrane Separators, Leukapheresis Disposables
3) By Application: Research Application, Cancer Research, Immunology Research, Therapeutics Application, Hematologic Disorders, Autoimmune Diseases, Other Applications
4) By End User: Blood Component Providers And Blood Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals And Transfusion Centers
Subsegments:
1) By Granulocyte Apheresis: Neutrophil Apheresis, Eosinophil Apheresis, Basophil Apheresis
2) By Lymphocyte Apheresis: T-Cell Apheresis, B-Cell Apheresis, Natural Killer (NK) Cell Apheresis
3) By Monocyte Apheresis: Classical Monocytes, Non-Classical Monocytes, Intermediate Monocytes
Which Market Trends Are Creating New Opportunities In The Leukapheresis Market?
Key companies active in the leukapheresis market are concentrating on advancements, such as the development of GMP-grade leukopaks, to elevate the quality and efficiency of cell therapy manufacturing. GMP-grade leukopaks are products derived from leukapheresis, processed under stringent good manufacturing practice (GMP) standards, which ensures the high viability and functionality of collected cells for therapeutic uses. For instance, in November 2024, Sanguine Biosciences, a US-based biotechnology company, unveiled LeukoCer, a GMP-grade leukopak designed to streamline workflows and accelerate cell therapy development. LeukoCert offers high-quality starting materials available in fresh whole or half packs, produced according to strict GMP standards, thereby empowering researchers to advance their investigations and bring new cell therapies to market more quickly.
Who Are The Key Players Driving Competition In The Leukapheresis Market?
Major companies operating in the leukapheresis market are Fresenius Kabi, Grifols S.A., Terumo BCT Inc., Nikkiso Co., Haemonetics Corporation, Macopharma, MEDICA S.p.A, Caltag Medsystems Ltd., Miltenyi Biotec, Puriblood Medical, Cytopheron Technologies, STEMCELL Technologies Inc., Discovery Life Sciences, BioIVT LLC, StemExpress LLC, AllCells LLC, HemaCare Corporation, Key Biologics LLC, Immune Therapy Holdings AB, Cellsep Laboratories
Read the full leukapheresis market report here:
https://www.thebusinessresearchcompany.com/report/leukapheresis-global-market-report
How Is The Leukapheresis Market Distributed Across Key Geographic Regions?
North America was the largest region in the leukapheresis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukapheresis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Leukapheresis Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24277&type=smp
Browse Through More Reports Similar to the Global Leukapheresis Market 2026, By The Business Research Company
Leqembi Market Report 2026
https://www.thebusinessresearchcompany.com/report/leqembi-global-market-report
Leukemia Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
Chronic Myeloid Leukemia Treatment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model